Medartis Holding AG / Key word(s): Investment/Mergers & Acquisitions 17-Jul-2025 / 06:59 CET/CEST PRESS RELEASE Release of an ad hoc announcement pursuant to Art. 53 LR. The issuer is solely responsible for the content of this announcement.
|
Medartis acquires remaining 53% stake in KeriMedical
Earlier from Medartis
- Medartis shareholders endorse Board proposals with strong support at AGM 2025
- Press release 2024 full-year results
- Presentation 2024 full-year results
- Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA margin from 17% to 19%
- Medartis reports 13% revenue growth on Group level, driven by strong regional growth in the US (21%) and EMEA (18%) –improvement of EBITDA* margin to 17%
Later from Medartis
- Medartis delivers 15.3% organic sales growth in H1 and lifts sales guidance for the full-year
- Publication of Medartis 2025 half-year results
- Slide presentation of Medartis' half-year results 2025
- First TOUCH® CMC 1 Prosthesis Implanted in the United States
- Medartis appoints Peter Hackel as new Chief Financial Officer
Follow Medartis into a list and get an email when it puts out news.
Follow Medartis